Other News To Note
Wednesday, July 6, 2011
Sorrento Therapeutics Inc., of San Diego, received a Small Business Technology Transfer Research grant from the National Institute of Allergy and Infectious Diseases in support of its antibody therapeutics and vaccines for Staphylococcus aureus, including methicillin-resistant strains. The Phase I grant is worth $600,000 over two years, with possible Phase II funding of $1 million per year for three years.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.